Anti-TNFalpha blockers, autoantibodies and autoimmune diseases

scientific article published on 17 June 2009

Anti-TNFalpha blockers, autoantibodies and autoimmune diseases is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.JBSPIN.2008.12.008
P698PubMed publication ID19539516
P5875ResearchGate publication ID26304323

P2093author name stringPaola Caramaschi
Alessandro Volpe
Domenico Biasi
Lisa Maria Bambara
Ilaria Tinazzi
Sara Pieropan
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectautoantibodyQ785022
P304page(s)333-342
P577publication date2009-06-17
P1433published inJoint Bone SpineQ15752403
P1476titleAnti-TNFalpha blockers, autoantibodies and autoimmune diseases
P478volume76

Reverse relations

cites work (P2860)
Q52603256Analytical variability in the determination of anti-double-stranded DNA antibodies: the strong need of a better definition of the old and new tests.
Q56974534Autoantibodies in psoriatic patients treated with anti-TNF-α therapy
Q45032600Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats
Q33958127Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity
Q48192268Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha.
Q64245283Enhanced Therapeutic Effect of RGD-Modified Polymeric Micelles Loaded With Low-Dose Methotrexate and Nimesulide on Rheumatoid Arthritis
Q33654733Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease
Q40576369Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors
Q38125529TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?
Q36394266The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests
Q34339359Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus
Q38087506Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans

Search more.